01 1ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
02 1ACRIVASTINE; PSEUDOEPHEDRINE HYDROCHLORIDE
03 7ALPROSTADIL
04 1ASPIRIN; OXYCODONE HYDROCHLORIDE
05 2ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE
06 1Acetylsalicylic Acid; Dipyridamole
07 1CLINDAMYCIN PHOSPHATE
08 2CYANOCOBALAMIN
09 1DALBAVANCIN (DALBAVANCIN HYDROCHLORIDE)
10 2FROVATRIPTAN (FROVATRIPTAN SUCCINATE)
11 1FROVATRIPTAN SUCCINATE
12 2HISTRELIN ACETATE
13 1ISOSORBIDE DINITRATE
14 1MEGESTROL ACETATE
15 2METHOCARBAMOL
16 2METHOXYFLURANE
17 7OXYMORPHONE HYDROCHLORIDE
18 2PENBUTOLOL SULFATE
19 2PITOLISANT HYDROCHLORIDE
20 2SUMATRIPTAN SUCCINATE
21 3TESTOSTERONE
22 1TESTOSTERONE UNDECANOATE
23 4THEOPHYLLINE
24 1Testosteron
25 1Testosterone
26 1VALRUBICIN
27 3Zonisamide
01 2BOCA PHARMA LLC
02 40ENDO OPERATIONS
03 7ENDO OPERATIONS LTD.
04 5Endo Ventures Limited
05 1Endo Ventures Unlimited Company
01 5CAPSULE, EXTENDED RELEASE;ORAL
02 1CAPSULE;ORAL
03 1Capsule For Inhalation
04 1GEL, METERED;NASAL
05 1GEL, METERED;TRANSDERMAL
06 1GEL;TRANSDERMAL
07 3Hard Capsule
08 2IMPLANT;SUBCUTANEOUS
09 7INJECTABLE;INJECTION
10 1INJECTABLE;INTRAMUSCULAR
11 2INJECTABLE;SUBCUTANEOUS
12 1KIT
13 1PELLET;IMPLANTATION
14 1POWDER FOR SOLUTION
15 1SOLUTION
16 1SOLUTION;INTRAVESICAL
17 1SOLUTION;TOPICAL
18 1SPRAY, METERED;NASAL
19 1SUSPENSION;ORAL
20 4TABLET
21 7TABLET, EXTENDED RELEASE;ORAL
22 9TABLET;ORAL
23 2Transdermal Gel
01 10.005MG/VIAL
02 20.01MG/VIAL
03 20.02MG/VIAL
04 20.04MG/VIAL
05 10.5MG/INH
06 10.5MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
07 2100MG
08 210MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
09 110MG/0.5GM ACTUATION **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
10 1125MG/ML
11 115MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
12 22.5MG
13 1200MG
14 1200mg;25mg
15 120MG
16 220MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
17 125MG
18 1300MG
19 130MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
20 1325MG;2.25MG;0.19MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
21 1325MG;4.5MG;0.38MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
22 1325MG;4.8355MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
23 1400MG
24 140MG
25 140MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
26 140MG/ML
27 1500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
28 1500MG/VIAL
29 450MG
30 150MG/5GM PACKET
31 150mg
32 15MG
33 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
34 17.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
35 1712.8MG;60MG;32MG
36 1750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
37 1750MG/3ML (250MG/ML)
38 175MG
39 18MG;60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
40 299.9%
41 1EQ 1% BASE
42 1EQ 2.5MG BASE
43 1EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML)
44 1EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
01 7Canada
02 3Malta
03 1Spain
04 2Sweden
05 42USA
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
Dosage Form : TABLET;ORAL
Brand Name : ACETAMINOPHEN, CAFFEINE, ...
Dosage Strength : 712.8MG;60MG;32MG
Packaging :
Approval Date : 2007-04-03
Application Number : 40701
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : Deregistered
Registration Country : Sweden
Acetylsalicylic Acid; Dipyridamole
Dosage Form : Capsule For Inhalation
Brand Name : Atranipar
Dosage Strength : 200mg;25mg
Packaging :
Approval Date : 22-09-2017
Application Number : 2.02E+13
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : DISCN
Registration Country : USA
ACRIVASTINE; PSEUDOEPHEDRINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Brand Name : SEMPREX-D
Dosage Strength : 8MG;60MG **Federal Reg...
Packaging :
Approval Date : 1994-03-25
Application Number : 19806
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : INJECTABLE;INJECTION
Brand Name : EDEX
Dosage Strength : 0.005MG/VIAL
Packaging :
Approval Date : 1997-06-12
Application Number : 20649
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : INJECTABLE;INJECTION
Brand Name : EDEX
Dosage Strength : 0.01MG/VIAL
Packaging :
Approval Date : 1997-06-12
Application Number : 20649
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : INJECTABLE;INJECTION
Brand Name : EDEX
Dosage Strength : 0.02MG/VIAL
Packaging :
Approval Date : 1997-06-12
Application Number : 20649
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : INJECTABLE;INJECTION
Brand Name : EDEX
Dosage Strength : 0.04MG/VIAL
Packaging :
Approval Date : 1997-06-12
Application Number : 20649
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : INJECTABLE;INJECTION
Brand Name : EDEX
Dosage Strength : 0.01MG/VIAL
Packaging :
Approval Date : 1998-07-30
Application Number : 20649
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : INJECTABLE;INJECTION
Brand Name : EDEX
Dosage Strength : 0.02MG/VIAL
Packaging :
Approval Date : 1998-07-30
Application Number : 20649
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : INJECTABLE;INJECTION
Brand Name : EDEX
Dosage Strength : 0.04MG/VIAL
Packaging :
Approval Date : 1998-07-30
Application Number : 20649
Regulatory Info : RX
Registration Country : USA
Endo International is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find Glycopyrronium Bromide bulk offered by Endo International
